Tracheotomy With and Without Dual Antiplatelet Therapy (PDT and (D)APT)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05058469 |
Recruitment Status :
Recruiting
First Posted : September 27, 2021
Last Update Posted : December 8, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Platelet-inhibiting drugs are often used after vascular interventions. Patients who require such therapies are often critically ill, are treated in intensive care units and often require long-term ventilation. For long-term ventilation a tracheotomy is necessary, which is usually performed as a percutaneous dilatative tracheotomy (PDT). As part of this intervention, there is (theoretically) an increased risk of bleeding/an increased rate of complications in patients with a antiplatelet therapy. In addition, there are various techniques for performing a PDT.
The current study aims to investigate the frequency of bleeding/complications taking into account the technique used in PDT.
Condition or disease | Intervention/treatment |
---|---|
Tracheostomy Hemorrhage | Device: Tracheotomy |
Study Type : | Observational |
Estimated Enrollment : | 300 participants |
Observational Model: | Cohort |
Time Perspective: | Retrospective |
Official Title: | Evaluation of the Safety of Percutaneous Tracheotomies in Intensive Care Patients With and Without Antiplatelet Therapy and Comparison of Two Tracheotomy Techniques |
Actual Study Start Date : | October 1, 2022 |
Estimated Primary Completion Date : | June 2024 |
Estimated Study Completion Date : | December 2024 |
Group/Cohort | Intervention/treatment |
---|---|
Tracheotomy without antiplatelet therapy+technique 1 |
Device: Tracheotomy
Tracheotomy in patients +/- antiplatelet therapy |
Tracheotomy under antiplatelet therapy+technique 1 |
Device: Tracheotomy
Tracheotomy in patients +/- antiplatelet therapy |
Tracheotomy without antiplatelet therapy+technique 2 |
Device: Tracheotomy
Tracheotomy in patients +/- antiplatelet therapy |
Tracheotomy under antiplatelet therapy+technique 2 |
Device: Tracheotomy
Tracheotomy in patients +/- antiplatelet therapy |
- Measurement of bleeding during Percutaneous Dilational Tracheostomy (PDT) with and without antiplatelet therapy (AP). [ Time Frame: 3 days ]
- bleeding (yes/no)
- intervention (yes/no)
- decrease (>= 1 g/dl) of hemoglobin (yes/no)
- number of blood transfusion(s)
- - Does the technique of PDT affect the bleeding rate? - How often are recognizable cartilage pin fractures in the context of a PDT? - Influence of AP and PDT technology on the frequency of need for a blood transfusion? [ Time Frame: 14 days ]cartilage pin fractures seen in endoscopy
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Patients who underwent Percutaneous Dilational Tracheostomy
Exclusion Criteria:
- none
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05058469
Contact: Dirk Bandorski, MD | +496043804212 | d.bandorski@asklepios.com |
Germany | |
Neurologische Klinik Bad Salzhausen | Recruiting |
Nidda, Germany, 63667 | |
Contact: Dirk Bandorski, MD +496043804212 d.bandorski@asklepios.com | |
Contact: Jens Allendörfer, MD |
Responsible Party: | Asklepios Neurological Clinic Bad Salzhausen |
ClinicalTrials.gov Identifier: | NCT05058469 |
Other Study ID Numbers: |
PDT and (D)APT |
First Posted: | September 27, 2021 Key Record Dates |
Last Update Posted: | December 8, 2023 |
Last Verified: | December 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Hemorrhage Pathologic Processes |